Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
7(100.0%)
7Total
N/A(7)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT07178951Not ApplicableRecruiting

Neurolysis for the Treatment of Medial Chronic Knee Pain Due to Osteoarthritis

Role: lead

NCT06053255Not ApplicableRecruiting

Use of the Neurolyser XR for the Treatment of Low Back Pain Related to Sacroiliitis

Role: lead

NCT05154448Not ApplicableCompleted

Double Arm Pivotal Study to Evaluate the Neurolyser XR for the Treatment of Chronic Low Back Pain

Role: lead

NCT05396495Not ApplicableUnknown

Safety and Feasibility of the NeurolyserXR for Sacroiliac Joint Pain

Role: lead

NCT04519541Not ApplicableCompleted

RAMBAM 021: Safety and Initial Feasibility of the Neurolyser XR for the Treatment of Chronic Low Back Pain

Role: lead

NCT04129034Not ApplicableUnknown

Safety and Initial Feasibility of Using the Neurolyser XR Device for the Treatment of Axial Chronic Low Back Pain

Role: lead

NCT05122611Completed

Post Lumbar Radiofrequency Neurotomy Imaging

Role: lead

NCT03321344Not ApplicableCompleted

Safety and Initial Feasibility of Using the Neurolyser for Facet Related Low Back Pain

Role: lead

All 8 trials loaded